1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Cold, Cough and Sore Throat Remedies Market: Oral Syrups Segment Will Remain the Most Attractive and Dominant Dosage Type Segment Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016 – 2026

Cold, Cough and Sore Throat Remedies Market: Oral Syrups Segment Will Remain the Most Attractive and Dominant Dosage Type Segment Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016 – 2026

  • March 2017
  • 224 pages
  • ID: 4911722
  • Format: PDF
  • Future Market Insight Global & Consulting Pvt Ltd

Summary

Table of Contents

The oral syrups segment is expected to dominate the global cold, cough and sore throat remedies market in the coming decade

Oral syrups segment is expected to expand at 2.9% CAGR over the estimated period and be valued more than US$ 10 Bn by the end of 2026. The segment is expected to create absolute $ opportunity of a little more than US$ 300 Mn in 2017 over 2016.

The segment is the most acceptable dosage form for cough, cold, and sore throat medicines due to ease of administration and pleasant taste. The oral syrups segment dominated the global cold, cough and sore throat remedies market in terms of revenue in 2016 and the trend is projected to continue throughout the forecast period. Oral syrups segment is the most attractive segment, with attractiveness index of 1.5 over the forecast period.

Pleasant taste and easy intake of oral syrups are the key factors boosting segmental growth during the forecast period
The majority of paediatric and geriatric patients prefer liquid as a delivery method over solid dosage forms, which is attributed to high proportion of oral syrups in the global cold, cough and sore throat remedies market. There is large scale adoption of oral syrups by pharmacy chains, especially in European countries, which is expected to fuel the sales of oral syrups in the global market. Most of the oral syrups are OTC (Over-the-Counter) drugs which do not need a doctor’s prescription.

Consumers are conditioned to treat cold, cough and sore throat with OTC drugs than to seek healthcare professionals and this propels the growth of the oral syrups segment across the globe. Continuous launch of new and improved drug types and increasing investment in research and development by manufacturers in oral syrups would lead to the growth of the oral syrups segment in the global cold, cough and sore throat remedies market. An intake of oral syrups is suitable for all patients irrespective of their age. Particularly, oral syrups are prescribed mostly for children and elderly patients and this factor is creating a positive impact on the oral syrups segment.

Emerging markets such as Brazil, Russia, India and China represent the larger market for OTCs and generics. Pharmaceuticals industry in these countries is dominated by the private sector, where pharma companies can reap larger revenue from the strong sales of oral syrups. The oral syrups segment is projected to grow in North America during 2016-2026

Oral syrups segment dominated the North America cold, cough and sore throat remedies market by doses type segment in terms of revenue in 2016, and the trend is projected to grow throughout the forecast period. Oral syrups segment is the most attractive segment in the North America cold, cough and sore throat remedies market, with attractiveness index of 1.5 over the forecast period. Revenue from the oral syrups segment is anticipated to increase at a CAGR of 1.9% over 2016–2026, to reach more than US$ 3,000 Mn by 2026.

OTC cough syrups for children are receiving exceptional attention in the U.S. by regulators, physicians and parents due to safety concerns. In the last 3 years, FDA has withdrawn more than 200 cough syrups containing hydrocodone from the market.

In Latin America, revenue from the oral syrups segment is anticipated to increase at a CAGR of 3.6% over 2016–2026, to reach more than US$ 500 Mn by 2026. The segment is expected to record attractiveness index of 1.7 over the forecast period in Western Europe. Revenue from the oral syrups segment is anticipated to increase at a CAGR of 4.1% over 2016–2026, to reach a market value of a little more than US$ 5,000 Mn by 2026 in the APEJ cold, cough and sore throat remedies market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Airway Clearance Systems Market Research Report by Device Type, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 3949
  • August 2020
  • 157 pages

Airway Clearance Systems Market Research Report by Device Type (Flutter Mucus Clearance Device, High Frequency Chest Wall Oscillation, Intrapulmonary Percussive Ventilation, Oscillatory Positive Expiratory ...

  • World
  • APAC
  • Respiratory Disease
  • Home Healthcare
  • Industry analysis

Boehringer Ingelheim $ 3000 July 2020


ref:plp2017

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on